Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - PRECISION BIOSCIENCES INC | dtil-ex322_1115.htm |
| EX-32.1 - EX-32.1 - PRECISION BIOSCIENCES INC | dtil-ex321_1114.htm |
| EX-31.2 - EX-31.2 - PRECISION BIOSCIENCES INC | dtil-ex312_1117.htm |
| EX-31.1 - EX-31.1 - PRECISION BIOSCIENCES INC | dtil-ex311_1116.htm |
| EX-21.1 - EX-21.1 - PRECISION BIOSCIENCES INC | dtil-ex211_789.htm |
| EX-10.14 - EX-10.14 - PRECISION BIOSCIENCES INC | dtil-ex1014_281.htm |
| EX-10.11 - EX-10.11 - PRECISION BIOSCIENCES INC | dtil-ex1011_1877.htm |
| EX-10.9 - EX-10.9 - PRECISION BIOSCIENCES INC | dtil-ex109_787.htm |
| EX-10.6 - EX-10.6 - PRECISION BIOSCIENCES INC | dtil-ex106_280.htm |
| EX-10.5 - EX-10.5 - PRECISION BIOSCIENCES INC | dtil-ex105_279.htm |
| EX-10.1 - EX-10.1 - PRECISION BIOSCIENCES INC | dtil-ex101_786.htm |
| EX-4.5 - EX-4.5 - PRECISION BIOSCIENCES INC | dtil-ex45_1557.htm |
| 10-K - 2020 10-K - PRECISION BIOSCIENCES INC | dtil-10k_20201231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-230671 on Form S-8 and Registration Statement No. 333-238857 on Form S-3 of our report dated March 18, 2021, relating to the financial statements of Precision BioSciences, Inc., appearing in this Annual Report on Form 10-K for the year ended December 31, 2020.
/s/ Deloitte & Touche LLP
Raleigh, North Carolina
March 18, 2021